Story perspectives

Anew Labs Closes $290M Seed Round at $1.5B Valuation

By Drooid · Sep 18, 2026, 6:32 AM UTC · How we work

Summary

Story summary

Anew Labs closed a $290 million seed round, valuing the company at $1.5 billion.
ByteDance kept a 56% ownership stake after the financing.
Investors included HSG, IDG Capital, Hillhouse Investment, 5 Y Capital, Gaorong Ventures and others.
Anew Labs operates AI models AnewFold, Protenix (open-source AlphaFold 3 replica) and AnewOmni.
Its pipeline includes four drug candidates, featuring a small-molecule inhibitor of all three IL-17 dimers, presented by Chris Li at Immunology2026.

1 of 1

Story summary

Anew Labs closed a $290 million seed round, valuing the company at $1.5 billion.
ByteDance kept a 56% ownership stake after the financing.
Investors included HSG, IDG Capital, Hillhouse Investment, 5 Y Capital, Gaorong Ventures and others.
Anew Labs operates AI models AnewFold, Protenix (open-source AlphaFold 3 replica) and AnewOmni.
Its pipeline includes four drug candidates, featuring a small-molecule inhibitor of all three IL-17 dimers, presented by Chris Li at Immunology2026.